We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

112 hedge funds and large institutions have $311M invested in Accelerate Diagnostics in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

9% less funds holding

Funds holding: 123 → 112 (-11)

22% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 36

31% less capital invested

Capital invested by funds: $448M → $311M (-$137M)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

63% less call options, than puts

Call options by funds: $1.18M | Put options by funds: $3.18M

Holders
112
Holders Change
-11
Holders Change %
-8.94%
% of All Funds
2.26%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
28
Reduced
36
Closed
19
Calls
$1.18M
Puts
$3.18M
Net Calls
-$2M
Net Calls Change
+$787K

Top Buyers

1
CC
Chicago Capital
Illinois
+$16.8M
2
N
Nuveen
North Carolina
+$3.16M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.82M
4
Bank of America
Bank of America
North Carolina
+$1.6M
5
First Trust Advisors
First Trust Advisors
Illinois
+$1.25M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$4.77M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$4.11M
3
SM
Senvest Management
New York
-$4M
4
Axa
Axa
France
-$3.33M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$391K -$72.9K -525 -13%
CL
52
CSS LLC
Illinois
$385K +$2.78K +20 +0.6%
MWNA
53
Marshall Wace North America
New York
$368K -$252K -1,818 -35%
CIBC Private Wealth Group
54
CIBC Private Wealth Group
Georgia
$368K +$479K +3,448 New
TRCT
55
Tower Research Capital (TRC)
New York
$352K +$375K +2,704 +455%
UBS AM
56
UBS AM
Illinois
$330K +$221K +1,595 +106%
New York State Common Retirement Fund
57
New York State Common Retirement Fund
New York
$318K – – –
Mitsubishi UFJ Asset Management
58
Mitsubishi UFJ Asset Management
Japan
$298K -$117K -846 -23%
Goldman Sachs
59
Goldman Sachs
New York
$290K -$905K -6,518 -71%
SWM
60
SeaCrest Wealth Management
New York
$287K – – –
Two Sigma Advisers
61
Two Sigma Advisers
New York
$284K -$1.03M -7,390 -74%
CCB
62
Cutter & Co Brokerage
Missouri
$273K +$11.5K +83 +3%
Asset Management One
63
Asset Management One
Japan
$268K – – –
MW
64
Marcum Wealth
Ohio
$234K – – –
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$204K – – –
AIG
66
American International Group
New York
$198K -$694 -5 -0.3%
FBC
67
Fairfield, Bush & Co
Connecticut
$194K -$48.6K -350 -16%
Arrowstreet Capital
68
Arrowstreet Capital
Massachusetts
$190K -$1.22M -8,760 -83%
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$190K – – –
ECM
70
ExodusPoint Capital Management
New York
$186K +$243K +1,748 New
SFI
71
Susquehanna Fundamental Investments
Pennsylvania
$185K – – –
Citadel Advisors
72
Citadel Advisors
Florida
$183K +$239K +1,719 New
Deutsche Bank
73
Deutsche Bank
Germany
$178K +$12.1K +87 +5%
MIM
74
MetLife Investment Management
New Jersey
$157K – – –
MML Investors Services
75
MML Investors Services
Massachusetts
$153K -$229K -1,646 -53%
1 2
3
4 5

AXDX Hedge Fund Activity: Q3 2020 in Review

112 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2020, worth a combined $311M — down 31% from $448M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of AXDX and 8 opened new positions — a net loss of 11 holders — while 36 trimmed existing stakes and 28 added.

The largest buyer was Chicago Capital, adding an estimated $16.8M. The largest seller was Morgan Stanley, cutting an estimated $4.77M.

  • 112 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2020, down from 123 in Q2 2020.
  • Funds reported $311M of Accelerate Diagnostics stock for Q3 2020, down 31% quarter-over-quarter.
  • 8 funds opened new Accelerate Diagnostics positions in Q3 2020 and 19 closed out, a net change of -11 holders.
  • The largest Accelerate Diagnostics buyer in Q3 2020 was Chicago Capital, an estimated $16.8M added.
  • The largest Accelerate Diagnostics seller in Q3 2020 was Morgan Stanley, an estimated $4.77M sold.

Based on aggregated 13F filings for Q3 2020.